INFLUVAC SUB-UNIT(ΑΝΤΙΓΡΙΠΙΚΟ) (15+15+15)MCG/0,5ML PF.SYR (1δόση) ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

influvac sub-unit(αντιγριπικο) (15+15+15)mcg/0,5ml pf.syr (1δόση) ενεσιμο εναιωρημα σε προγεμισμενη συριγγα

bgp ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. bgp ΠΡΟΪΟΝΤΑ Μ.Ε.Π.Ε. (0000011228) Αγ. Δημητρίου 63, Α - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224); b/washington/02/2019 - like strain (b/washington/02/2019, wild type) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15)mcg/0,5ml pf.syr (1δόση) - ineof03055 a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15.000000 mcg; ineof03056 a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224) 15.000000 mcg; ineof03029 b/washington/02/2019 - like strain (b/washington/02/2019, wild type) 15.000000 mcg - influenza, purified antigen

INFLUVAC SUB-UNIT SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

influvac sub-unit suspension for injection in pre-filled syringe

mylan ire healthcare limited (0000010616) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224); b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection in pre-filled syringe - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215) (8000004843) 15ug; a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224) (8000004845) 15ug; b/washington/02/2019-like strain (b/washington/02/2019, wild type) (8000004816) 15ug - influenza, purified antigen

FLUARIX TETRA INJ.SU.PFS (15+15+15+15)mcg/0,5ml PF.SYR (1 δόση) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

fluarix tetra inj.su.pfs (15+15+15+15)mcg/0,5ml pf.syr (1 δόση)

glaxosmithkline biologicals sa, rixensart, belgium rue de l' institut 89,, 1330 rixensart - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221); b/washington/02/2019 - like strain (b/washington/02/2019, wild type); b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0,5ml pf.syr (1 δόση) - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221) 15mcg; b/washington/02/2019 - like strain (b/washington/02/2019, wild type) 15mcg; b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen

VAXIGRIP TETRA® INJ.SU.PFS (15+15+15+15)MCG/0.5ML PF.SYR (1 δόση). Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vaxigrip tetra® inj.su.pfs (15+15+15+15)mcg/0.5ml pf.syr (1 δόση).

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221); b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11); b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0.5ml pf.syr (1 δόση). - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221) 15mcg; b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) 15mcg; b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen

FLUAD (ΑΝΤΙΓΡΙΠΠΙΚΟ ΕΜΒΟΛΙΟ) (15+15+15) MCG/0,5ML PF.SYR (1 δόση) ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

fluad (αντιγριππικο εμβολιο) (15+15+15) mcg/0,5ml pf.syr (1 δόση) ενεσιμο εναιωρημα σε προγεμισμενη συριγγα

seqirus s.r.l., italy (0000011732) via del pozzo 3/a, siena, 53035 - a/guandong-maonan/swl 1536/2019 (h1n1) pdm09 - like strain (a/victoria/2454/2019 ivr-207); a/hong kong/2671/2019 (h3n2) - like strain (a/hong kong/2671/2019 ivr-208); b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15) mcg/0,5ml pf.syr (1 δόση) - ineof03026 a/guandong-maonan/swl 1536/2019 (h1n1) pdm09 - like strain (a/victoria/2454/2019 ivr-207) 15.000000 mcg; ineof03028 a/hong kong/2671/2019 (h3n2) - like strain (a/hong kong/2671/2019 ivr-208) 15.000000 mcg; ineof03030 b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) 15.000000 mcg - influenza vaccines - influenza vaccines

AGRIPPAL(ΑΝΤΙΓΡΙΠΠΙΚΟ ΕΜΒΟΛΙΟ) INJ.SU.PFS (15+15+15)MCG/0,5ML PF.SYR (1 δόση) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

agrippal(αντιγριππικο εμβολιο) inj.su.pfs (15+15+15)mcg/0,5ml pf.syr (1 δόση)

novartis vaccines and diagnostics srl, siena, italy via fiorentina 1,, 53100, siena - a/california/7/2009 (h1n1)pdm09- derived strain used nymc x-181; a/victoria/361/2011(h3n2)-like strain used nymc x-223a derived from a/texas/50/2012; b/massachussets/2/2012-like strain used b/massachusetts/2/2012 wild type - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15)mcg/0,5ml pf.syr (1 δόση) - a/california/7/2009 (h1n1)pdm09- derived strain used nymc x-181 15mcg; a/victoria/361/2011(h3n2)-like strain used nymc x-223a derived from a/texas/50/2012 15mcg; b/massachussets/2/2012-like strain used b/massachusetts/2/2012 wild type 15mcg - influenza, purified antigen

INFLUVAC SUB-UNIT TETRA® INJ.SU.PFS (15+15+15+15)MCG/0.5ML PF.SYR. (1 δόση) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

influvac sub-unit tetra® inj.su.pfs (15+15+15+15)mcg/0.5ml pf.syr. (1 δόση)

viatris healthcare limited, ireland damastown industrial park, - dublin - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238); a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224); b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26); b/phuket/3073/2013-like strain (b/yamagata/16/88 lineage) (b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0.5ml pf.syr. (1 δόση) - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/cambodia/e0826360/2020, ivr-224) 15mcg; b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26) 15mcg; b/phuket/3073/2013-like strain (b/yamagata/16/88 lineage) (b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen

EFLUELDA® INJ.SU.PFS (60+60+60+60)MCG/0.7ML PF.SYR (1 ΔΟΣΗ) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

efluelda® inj.su.pfs (60+60+60+60)mcg/0.7ml pf.syr (1 δοση)

sanofi pasteur, lyon, france 14 espace henry vallee, 69007 lyon - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238); a/darwin/9/2021 (h3n2) - like strain a/darwin/9/2021, san-010); b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26); b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (60+60+60+60)mcg/0.7ml pf.syr (1 ΔΟΣΗ) - a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022, ivr-238) 60mcg; a/darwin/9/2021 (h3n2) - like strain a/darwin/9/2021, san-010) 60mcg; b/austria/1359417/2021 - like strain b/austria/1359417/2021, bvr-26) 60mcg; b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) 60mcg - influenza, purified antigen

INFLUVAC SUB-UNIT TETRA 15MCG/DOSE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

influvac sub-unit tetra 15mcg/dose suspension for injection in pre-filled syringe

viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2)-like strain (a/tasmania/503/2020, ivr-221); b/washington/02/2019-like strain (b/washington/02/2019, wild type) [victoria lineage]; b/phuket/3073/2013 – like strain (b/phuket/3073/2013, wild type) [yamagata lineage] - suspension for injection in pre-filled syringe - 15mcg/dose - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215) (8000004843) 15ug; a/cambodia/e0826360/2020 (h3n2)-like strain (a/tasmania/503/2020, ivr-221) (8000004848) 15ug; b/washington/02/2019-like strain (b/washington/02/2019, wild type) [victoria lineage] (8000004849) 15ug; b/phuket/3073/2013 – like strain (b/phuket/3073/2013, wild type) [yamagata lineage] (8000004705) 15ug - influenza, purified antigen

FLUARIX 15MCG/DOSE PER INFLUENZA STRAIN) SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

fluarix 15mcg/dose per influenza strain) suspension for injection in pre-filled syringe

glaxosmithkline(cyprus)ltd, cyprus - Β/shanghai/361/2002-ΣΑΝ ΣΤΈΛΕΧΟΣ a/california/7/2004 (h3n2)-like ΣΤΈΛΕΧΟΣ a/new caledonia/20/99ivr-116 - suspension for injection in pre-filled syringe - 15mcg/dose per influenza strain) - 8000002752 - b/shanghai/361/2002-like strain - 15 mcg; 8000002751 - a/california/7/2004 (h3n2)-like strain - 15 mcg; 8000002054 - a/new caledonia/20/99ivr-116 - 15 mcg - influenza, purified antigen